propranolol has been researched along with Hematoma in 3 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Hematoma: A collection of blood outside the BLOOD VESSELS. Hematoma can be localized in an organ, space, or tissue.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this case, we describe an evident hemorrhagic brainstem cavernous malformation successfully treated with a planned sequence of surgical evacuation of the hematoma followed by postoperative propranolol therapy." | 7.96 | Successful treatment of hemorrhagic brainstem cavernous malformation with hematoma evacuation and postoperative propranolol. ( Armstrong, J; Greenan, K; Hoffman, JE; Ryan, M; Wilkinson, C; Wittenberg, B, 2020) |
| "In this case, we describe an evident hemorrhagic brainstem cavernous malformation successfully treated with a planned sequence of surgical evacuation of the hematoma followed by postoperative propranolol therapy." | 3.96 | Successful treatment of hemorrhagic brainstem cavernous malformation with hematoma evacuation and postoperative propranolol. ( Armstrong, J; Greenan, K; Hoffman, JE; Ryan, M; Wilkinson, C; Wittenberg, B, 2020) |
| "The present case describes a new and unusual variant of thyrotoxicosis: transient hyperthyroxinemia following acute and massive hemorrhage into a previously normal thyroid gland." | 3.69 | Toxic hematoma: an unusual and previously undescribed type of thyrotoxicosis. ( Skowsky, WR, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffman, JE | 1 |
| Ryan, M | 1 |
| Wittenberg, B | 1 |
| Armstrong, J | 1 |
| Greenan, K | 1 |
| Wilkinson, C | 1 |
| Skowsky, WR | 1 |
| Ram, Z | 1 |
| Spiegelman, R | 1 |
| Findler, G | 1 |
| Hadani, M | 1 |
3 other studies available for propranolol and Hematoma
| Article | Year |
|---|---|
Successful treatment of hemorrhagic brainstem cavernous malformation with hematoma evacuation and postoperative propranolol.
Topics: Child, Preschool; Hemangioma, Cavernous; Hemangioma, Cavernous, Central Nervous System; Hematoma; Hu | 2020 |
Toxic hematoma: an unusual and previously undescribed type of thyrotoxicosis.
Topics: Aged; Antithyroid Agents; Female; Hematoma; Humans; Propranolol; Thyroid Diseases; Thyroid Function | 1995 |
Delayed postoperative neurological deterioration from prolonged sodium nitroprusside administration. Case report.
Topics: Brain Edema; Cerebral Hemorrhage; Coma; Craniotomy; Cyanides; Ferricyanides; Hematoma; Humans; Hyper | 1989 |